Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line

Neoplasia

Volumn 2, Issue 3, 2000, Pages 226-234

  Yi, Seung ^a   Tsao, Ming Sound ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Autocrine loop; Lung cancer; Scatter factor; Tumorigenicity

Indexed keywords

SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

EID: 0034129655     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900080     Document Type: Article

References (46)

1. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, and Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443.
2. Gheraldi E, Gray J, Stoker M, Perryman M, and Furlong R (1989). Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86, 5844-5848.
3. Weidner KM, Arakaki N, Hartmann G, Vandekerchihove J, Weingart SR, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, and Birchmeier W (1991). Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88, 7001-7005.
4. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeir W, Daikuhura Y, Tsubouchi H, Blasi F, and Comoglio PM (1992). Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor. EMBO J 11, 4825-4833.
5. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande WG, and Aaronson SA (1991). Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804.
6. Matsumoto K, and Nakamura T (1996). Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119, 591-600.
7. Weidner KM, Behrens J, Vandekerckhove J, and Birchmeier W (1990). Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 111, 2097-2103.
8. Montesano R, Matsumoto K, Nakamura T, and Orci L (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.
9. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, and Comoglio PM (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119, 629-641.
10. Birchmeier C, and Gherardi E (1998). Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8, 404-410.
11. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, and Merlino G (1997). Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 94, 701-706.
12. Rosen EM, Nigam SK, and Goldberg ID (1994). Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 127, 1783-1787.
13. To CTT, Tsao MS (1998). The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancer (review). Oncol Rep 5, 1013-1024.
14. Rong S, Segal S, Anver M, Resau JH, and Vande Woude GF (1994). Invasiveness and metastasis of NIH 3T3 cells induced by Methepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91, 4731-4735.
15. Jeffers M, Rong S, and Vande Woude GF (1996). Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74, 505-513.
16. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, and Jouanneau J (1994). Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9, 1091-1099.
17. Jeffers M, Rong S, and Vande Woude GF (1996). Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16, 1115-1125.
18. Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Lattara J, Goldberg ID, and Rosen EM (1997). Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice. Lab Invest 76, 339-353.
19. Harvey P, Warn A, Newman P, Perry LJ, Ball RY, and Warn RM (1996). Immunoreactivity for hepatocyte growth factor and its receptor, met, in human lung carcinomas and malignant mesothelioma. J Pathol 180, 389-394.
20. Olivero M, Rizzo M, Maddedu R, Casadio C, Pannacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG, Comoglio PM, and Di Renzo MF (1996). Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 74, 1862-1868.
21. Takanami I, Tanana F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T, and Kodaira S (1996). Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: and evaluation of their expression as prognostic markers. Oncology 53, 392-397.
22. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, and Landreneau RJ (1997). Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res 57, 433-439.
23. Rygaard K, Nakamura T, and Spang-Thomsen M (1993). Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer 67, 37-46.
24. Tsao MS, Liu N, Chen JR, Pappas J, Ho J, To C, Viallet J, Park M, and Zhu H (1998). Differential expression of Met/hepatocyte growth factor receptor in subtypes of non-small cell lung cancers. Lung Cancer 20, 1-16.
25. Yi S, Chen JR, Viallet J, Schwall RH, Nakamura T, and Tsao MS (1998). Paracrine effects of hepatocyte growth factor/scatter factor on non-small cell lung carcinoma cell lines. Br J Cancer 77, 2162-2170.
26. Phelps RM, Johnson BE, Ihde DC, Gazdar AF, Carbone DP, McClintock PR, Linnoila I, Mattews MJ, Bunn PA Jr, Carney D, Minna JD, and Mulshine JL (1996). NCI-Navy medical oncology branch cell line data base. J Cell Biochem Suppl 24, 32-91.
27. Dusty A, and Rosman GJ (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
28. Landau NR, and Littman DR (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol 66, 5110-5113.
29. Tsao MS, Zhu H, Giaid A, Viallet J, Nakamura T, and Park M (1993). Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ 4, 571-579.
30. Rodrigues GA, Naujokas M, and Park M (1991). Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol 11, 2962-2970.
31. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, and Ferrara N (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309.
32. Zioncheck TF, Richardson L, Liu J, Chang L, King KL, Bennett GL, Fugedi P, Chamow SM, Schwall RH, and Stack RJ (1995). Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem 270, 16871-16878.
33. Lam EW, Zwacka R, Engelhardt JF, Davidson BL, Domann EF Jr., Yan T, and Oberley LW (1997). Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells. Cancer Res 57, 5550-5556.
34. Tsao MS, Earp HS, and Grisham JW (1985). Gradation of carcinogen-induced capacity for achorage-independent growth in cultured rat liver epithelial cells. Cancer Res 45, 4428-4432.
35. Tsao MS, Liu N, Nicklee T, Shepherd F, and Viallet J (1997). Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Clin Cancer Res 3, 1807-1814.
36. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, and Johnston P (1997). Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 76, 565-577.
37. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, and Rosen EM (1993). Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90, 1937-1941.
38. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, and Wakisaka S (1998). Upregulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249, 73-77.
39. Gille J, Khalik M, Konig V, and Kaufmann R (1998). Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. J Invest Dermatol 111, 1160-1165.
40. Wojta J, Kaun C, Breuss JM, Koshelnick Y, Beckmann R, Hattey E, Mildner M, Weninger W, Nakamura T, Tschachler E, and Binder BR (1999). Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab Invest 79, 427-438.
41. Jeffers M, Rong S, and Vande Woude G (1996). Enhanced tumorigenicity and invasion/metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16, 1115-1125.
42. Ried S, Jager C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, and Lengyel E (1999). Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. J Biol Chem 274, 16377-16386.
43. Trusolino L, Serini G, Cecchini G, Besati C, Ambesi-Impiombato FS, Marchisio PC, and De Filippi R (1998). Growth factor-dependent activation of alphabeta3 integrin in normal epithelial cells: implication for tumour invasion. J Cell Biol 142, 1145-1156.
44. Taylor GA, Jeffers M, Webb CP, Koo H, Anver M, Sekiguchi K, and Vande Woude GF (1998). Decreased fibronectin expression in Met/HGF-mediated tumorigenesis. Oncogens 17, 1179-1183.
45. Matsumoto K, Date K, Ohmichi H, and Nakamura T (1996). Hepatocyte growth factor in lung morphogenesis and tumour invasion: role as a mediator in epithelium-mesenchyme and tumour-stroma interactions. Cancer Chemother Pharmacol 38, S42-S47.
46. Brinkmann V, Foroutan H, Sachs M, Weidner M, and Birchmeier W (1995). Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 131, 1573-1586.